Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dietary Yeasts Reduce Inflammation in Central Nerve System via Microflora.
DGPPN guideline on anxiety disorders and cognitive dysfunction in the elderly or patients with multiple sclerosis.
Efficacy of Intravenous Immunoglobulin in Neurological Diseases.
Combining genetic mapping with genome-wide expression in experimental autoimmune encephalomyelitis highlights a gene network enriched for T cell functions and candidate genes regulating autoimmunity.
Bilateral Optic Neuritis due to Malaria.
A forgotten aspect of the NICE reference case: an observational study of the health related quality of life impact on caregivers of people with multiple sclerosis.
PET imaging of demyelination and remyelination in the cuprizone mouse model for multiple sclerosis: A comparison between [(11)C]CIC and [(11)C]MeDAS.
Screening for inhibitors of microglia to reduce neuroinflammation.
Depressive syndromes in neurological disorders.
GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
T cell-activation in neuromyelitis optica lesions plays a role in their formation.
Improving drug delivery technology for treating neurodegenerative diseases.
Bone health in chronic neurological diseases: a focus on multiple sclerosis and parkinsonian syndromes.
TCR Transgenic Mice That Shed Light on Immune and Environmental Regulators in Multiple Sclerosis.
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
NK cells and their receptors in naive and rituximab-treated patients with anti-MAG polyneuropathy.
NMO spectrum disorders: how wide is the spectrum?
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.
Magnitude and concurrence of anxiety and depression among attendees with multiple sclerosis at a tertiary care Hospital in Oman.
[NLRP3 inflammasome and multiple sclerosis/EAE].
Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
Treatment of mood disorders in multiple sclerosis.
Anti-JC virus antibodies in rituximab-treated patients with neuromyelitis optica spectrum disorder.

Pages